Which are the causes of Abetalipoproteinemia?

Abetalipoproteinemia is a rare, inherited metabolic disorder caused by mutations in the MTTP gene, which prevents the body from properly absorbing dietary fats and fat-soluble vitamins. Because the liver and intestines cannot assemble lipoproteins, individuals with Abetalipoproteinemia experience severe nutritional deficiencies that impact the nervous system and eyes.

What causes Abetalipoproteinemia?

The primary cause of Abetalipoproteinemia is a genetic defect in the microsomal triglyceride transfer protein (MTP). Think of MTP as a "shipping clerk" in the cells of your intestines and liver; its job is to package fats into specialized carriers called lipoproteins (specifically chylomicrons and VLDL). In Abetalipoproteinemia, this clerk is missing or non-functional, meaning fats and fat-soluble vitamins (A, D, E, and K) cannot be transported into the bloodstream, leaving the body's tissues "starved" of essential nutrients.

Is Abetalipoproteinemia hereditary?

Yes, Abetalipoproteinemia follows an autosomal recessive inheritance pattern. This means that for a child to be born with the condition, they must inherit two copies of the mutated MTTP gene—one from each parent. Parents who carry only one copy of the mutation are typically asymptomatic carriers and do not show signs of the disease.

Are there environmental or external triggers?

Unlike some conditions, Abetalipoproteinemia is not triggered by environmental factors, infections, or lifestyle choices. It is strictly a genetic condition present from birth. While diet management is crucial for those diagnosed, the underlying cause remains the inability of the body to synthesize specific lipoproteins.

What does current research focus on?

Current research into Abetalipoproteinemia focuses on improving long-term outcomes through early diagnosis and aggressive vitamin supplementation. Scientists are investigating:

• Gene therapy approaches to restore MTP function in liver cells.


• New formulations of fat-soluble vitamins that may improve absorption in the gut.


• Long-term clinical monitoring of the 19 members within the DiseaseMaps.org community to better understand the variability in symptom progression.

Next steps

• Consult with a clinical geneticist to confirm a diagnosis via genetic testing.


• Work with a metabolic specialist or gastroenterologist to establish a high-dose fat-soluble vitamin regimen.


• Join the DiseaseMaps.org community to connect with other families navigating the challenges of Abetalipoproteinemia.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center.


• Orphanet: Portal for rare diseases and orphan drugs.


• Online Mendelian Inheritance in Man (OMIM) entry for Abetalipoproteinemia.